%PDF-1.4
%
71 0 obj
<>
endobj
2 0 obj
<>stream
Acrobat Distiller 9.4.0 (Macintosh)
application/pdf
CIR-13-0001 179..189
pinnacle
2016-02-04T23:29:16-08:00
Arbortext Advanced Print Publisher 9.1.406/W Unicode
2013-08-11T08:35:10+05:30
2016-02-04T23:29:16-08:00
uuid:f501b60b-1dd1-11b2-0a00-ac09279d8f00
uuid:f501b60f-1dd1-11b2-0a00-b30000000000
endstream
endobj
149 0 obj
<>
endobj
160 0 obj
<>
endobj
84 0 obj
<>
endobj
132 0 obj
<>
endobj
152 0 obj
<>
endobj
97 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[28.224 28.224 613.241 811.197]/Type/Page>>
endobj
204 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
209 0 obj
[215 0 R 216 0 R 217 0 R 218 0 R 219 0 R 220 0 R]
endobj
210 0 obj
<>stream
q
544.9595032 0 0 67.551178 48.0202484 723.448822 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 128.68979 624.99985 Tm
(2013;1:179-189. Published OnlineFirst July 17, 2013.)Tj
/T1_1 1 Tf
-9.66898 0 Td
(Cancer Immunol Res\240)Tj
/T1_0 1 Tf
0 1 TD
(\240 )Tj
0 1.00001 TD
(Jian Yan, Panyupa Pankhong, Thomas H. Shin, et al. )Tj
/T1_2 1 Tf
0 1 TD
(\240 )Tj
/T1_3 1 Tf
18 0 0 18 32 664.99997 Tm
(Reverse Transcriptase Stimulates Potent Antitumor Immunity)Tj
T*
(Highly Optimized DNA Vaccine Targeting Human Telomerase)Tj
ET
32 570 577 35 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 122.94202 577.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-7.55696 1 Td
(Updated version)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 143 569.99994 Tm
(\240 )Tj
/T1_0 1 Tf
16.28697 1 Td
( )Tj
0 0 1 rg
-14.67498 0 Td
(10.1158/2326-6066.CIR-13-0001)Tj
0 g
-1.61199 0 Td
(doi:)Tj
0 1.00001 TD
(Access the most recent version of this article at:)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 32 549.99997 Tm
(\240 )Tj
0 1 TD
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 32 529.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
32 490 577 40 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 122.94202 497.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-6.00198 1 Td
(Cited articles)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 143 489.99994 Tm
(\240 )Tj
/T1_0 1 Tf
33.1789 1 Td
( )Tj
0 0 1 rg
-33.1789 0 Td
(http://cancerimmunolres.aacrjournals.org/content/1/3/179.full.html#ref-l\
ist-1)Tj
0 g
0 1.00001 TD
(This article cites 58 articles, 20 of which you can access for free at:)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 32 469.99997 Tm
(\240 )Tj
0 1 TD
(\240 )Tj
ET
32 375 577 95 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 122.94202 437.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(E-mail alerts)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 297.4996 450 Tm
( related to this article or journal.)Tj
0 0 1 rg
-15.44996 0 Td
(Sign up to receive free email-alerts)Tj
ET
BT
0 g
/T1_0 1 Tf
11 0 0 11 122.94202 404.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-6.38997 1 Td
(Subscriptions)Tj
0.556 1.00001 Td
(Reprints and )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 143 407.99994 Tm
(\240 )Tj
7.96298 1 Td
(.)Tj
0 0 1 rg
-6.85099 0 Td
(pubs@aacr.org)Tj
0 g
-1.11199 0 Td
(at)Tj
0 1.00001 TD
(To order reprints of this article or to subscribe to the journal, contac\
t the AACR Publications Department)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 122.94202 382.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(Permissions)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 143 374.99994 Tm
(\240 )Tj
10.01696 1 Td
(.)Tj
0 0 1 rg
-10.01696 0 Td
(permissions@aacr.org)Tj
0 g
T*
(To request permission to re-use all or part of this article, contact the\
AACR Publications Department at)Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 281.40289 11 Tm
(on February 4, 2016. \251 2013 American Association for Cancer Research.\
)Tj
0 0 1 rg
-15.89294 0 Td
(cancerimmunolres.aacrjournals.org )Tj
0 g
-8.11398 0 Td
(Downloaded from )Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 168.67719 826 Tm
(Published OnlineFirst July 17, 2013; DOI: 10.1158/2326-6066.CIR-13-0001 \
)Tj
ET
endstream
endobj
214 0 obj
<>/Filter/FlateDecode/Height 193/Length 77582/Name/X/Subtype/Image/Type/XObject/Width 1557>>stream
HϋVs?BJR0PbpS*bAlmRǕi8.D:՚ %4N팝y̙g.y=yc{o ex] ~% `xy] ~% `xy] ~% `xy] ~% `xy] ~% `xy] ~% `xy] ~% `xy] ~% ,K4{Ud06:LXd "CQUUEڣЙy$!Bx$\o+e nۅ$2t6tz37j67YR)eTH,fI;M*JOBb[GaQeeNv}kj|%a